Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Urology Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Urology Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Urology Drugs Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Urology Drugs Market-Segmentation by Type
5.1 α (alpha) - blockers
5.2 5 α-reductase inhibitors
6 Global Urology Drugs Market-Segmentation by Application
6.1 Hospital
6.2 Clinic
6.3 Others
7 Global Urology Drugs Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 GP Pharm
8.1.1 GP Pharm Profile
8.1.2 GP Pharm Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 GP Pharm Product/Solution Launches and Enhancements Analysis
8.1.4 GP Pharm Business Overview/Recent Development/Acquisitions
8.2 Endo
8.2.1 Endo Profile
8.2.2 Endo Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Endo Product/Solution Launches and Enhancements Analysis
8.2.4 Endo Business Overview/Recent Development/Acquisitions
8.3 Tolmar
8.3.1 Tolmar Profile
8.3.2 Tolmar Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Tolmar Product/Solution Launches and Enhancements Analysis
8.3.4 Tolmar Business Overview/Recent Development/Acquisitions
8.4 Astellas
8.4.1 Astellas Profile
8.4.2 Astellas Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Astellas Product/Solution Launches and Enhancements Analysis
8.4.4 Astellas Business Overview/Recent Development/Acquisitions
9 Global Urology Drugs Market-Segmentation by Geography
10 North America
10.1 North America Urology Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Urology Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Urology Drugs Production Analysis from 2015-2020
10.4 North America Urology Drugs Consumption Analysis from 2015-2020
10.5 North America Urology Drugs Import and Export from 2015-2020
10.6 North America Urology Drugs Value, Production and Market Share by Type (2015-2020)
10.7 North America Urology Drugs Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Urology Drugs by Country (United States, Canada)
10.8.1 North America Urology Drugs Sales by Country (2015-2020)
10.8.2 North America Urology Drugs Consumption Value by Country (2015-2020)
10.9 North America Urology Drugs Market PEST Analysis
11 Europe
11.1 Europe Urology Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Urology Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Urology Drugs Production Analysis from 2015-2020
11.4 Europe Urology Drugs Consumption Analysis from 2015-2020
11.5 Europe Urology Drugs Import and Export from 2015-2020
11.6 Europe Urology Drugs Value, Production and Market Share by Type (2015-2020)
11.7 Europe Urology Drugs Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Urology Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Urology Drugs Sales by Country (2015-2020)
11.8.2 Europe Urology Drugs Consumption Value by Country (2015-2020)
11.9 Europe Urology Drugs Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Urology Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Urology Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Urology Drugs Production Analysis from 2015-2020
12.4 Asia-Pacific Urology Drugs Consumption Analysis from 2015-2020
12.5 Asia-Pacific Urology Drugs Import and Export from 2015-2020
12.6 Asia-Pacific Urology Drugs Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Urology Drugs Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Urology Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Urology Drugs Sales by Country (2015-2020)
12.8.2 Asia-Pacific Urology Drugs Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Urology Drugs Market PEST Analysis
13 Latin America
13.1 Latin America Urology Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Urology Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Urology Drugs Production Analysis from 2015-2020
13.4 Latin America Urology Drugs Consumption Analysis from 2015-2020
13.5 Latin America Urology Drugs Import and Export from 2015-2020
13.6 Latin America Urology Drugs Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Urology Drugs Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Urology Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Urology Drugs Sales by Country (2015-2020)
13.8.2 Latin America Urology Drugs Consumption Value by Country (2015-2020)
13.9 Latin America Urology Drugs Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Urology Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Urology Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Urology Drugs Production Analysis from 2015-2020
14.4 Middle East & Africa Urology Drugs Consumption Analysis from 2015-2020
14.5 Middle East & Africa Urology Drugs Import and Export from 2015-2020
14.6 Middle East & Africa Urology Drugs Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Urology Drugs Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Urology Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Urology Drugs Sales by Country (2015-2020)
14.8.2 Middle East & Africa Urology Drugs Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Urology Drugs Market PEST Analysis
15 Future Forecast of the Global Urology Drugs Market from 2020-2028
15.1 Future Forecast of the Global Urology Drugs Market from 2020-2028 Segment by Region
15.2 Global Urology Drugs Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Urology Drugs Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
